HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)
China · Delayed Price · Currency is CNY 3.560
-0.140 (-3.78%)
Sep 10, 2026, 2:40 PM CST
SHE:002437 Revenue
HARBIN GLORIA PHARMACEUTICALS Co., LTD had revenue of 467.96M CNY in the quarter ending June 30, 2026, a decrease of -14.64%. This brings the company's revenue in the last twelve months to 2.04B, down -11.90% year-over-year. In the year 2025, HARBIN GLORIA PHARMACEUTICALS Co., LTD had annual revenue of 2.14B, down -12.51%.
Revenue (ttm)
2.04B
Revenue Growth
-11.90%
P/S Ratio
4.04
Revenue / Employee
869.37K
Employees
2,350
Market Cap
8.25B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.14B | -305.28M | -12.51% |
| Dec 31, 2024 | 2.44B | -185.31M | -7.06% |
| Dec 31, 2023 | 2.63B | -481.91M | -15.51% |
| Jan 1, 2023 | 3.11B | -37.37M | -1.19% |
| Jan 1, 2022 | 3.15B | 90.36M | 2.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.